DSC Perfusion MRI-Derived Fractional Tumor Burden and Relative CBV Differentiate Tumor Progression and Radiation Necrosis in Brain Metastases Treated with Stereotactic Radiosurgery

• Published in: American journal of neuroradiology : AJNR 2022-05, Vol.43 (5), p.689-695
• Main Authors: Kuo, F, Ng, N N, Nagpal, S, Pollom, E L, Soltys, S, Hayden-Gephart, M, Li, G, Born, D E, Iv, M
• Format: Article
• Language: English
• Subjects: Adult Brain; Brain Neoplasms - diagnostic imaging; Brain Neoplasms - radiotherapy; Brain Neoplasms - surgery; Functional; Humans; Magnetic Resonance Imaging - methods; Necrosis - diagnostic imaging; Perfusion; Radiation Injuries - diagnostic imaging; Radiation Injuries - etiology; Radiosurgery - methods; Retrospective Studies; Tumor Burden
• ISSN: 0195-6108; 1936-959X
• DOI: 10.3174/ajnr.A7501

Differentiation between tumor and radiation necrosis in patients with brain metastases treated with stereotactic radiosurgery is challenging. We hypothesized that MR perfusion and metabolic metrics can differentiate radiation necrosis from progressive tumor in this setting. We retrospectively evaluated MRIs comprising DSC, dynamic contrast-enhanced, and arterial spin-labeling perfusion imaging in subjects with brain metastases previously treated with stereotactic radiosurgery. For each lesion, we obtained the mean normalized and standardized relative CBV and fractional tumor burden, volume transfer constant, and normalized maximum CBF, as well as the maximum standardized uptake value in a subset of subjects who underwent FDG-PET. Relative CBV thresholds of 1 and 1.75 were used to define low and high fractional tumor burden. Thirty subjects with 37 lesions (20 radiation necrosis, 17 tumor) were included. Compared with radiation necrosis, tumor had increased mean normalized and standardized relative CBV ( = .002) and high fractional tumor burden (normalized, = .005; standardized, = .003) and decreased low fractional tumor burden (normalized, = .03; standardized, = .01). The area under the curve showed that relative CBV (normalized = 0.80; standardized = 0.79) and high fractional tumor burden (normalized = 0.77; standardized = 0.78) performed the best to discriminate tumor and radiation necrosis. For tumor prediction, the normalized relative CBV cutoff of ≥1.75 yielded a sensitivity of 76.5% and specificity of 70.0%, while the standardized cutoff of ≥1.75 yielded a sensitivity of 41.2% and specificity of 95.0%. No significance was found with the volume transfer constant, normalized CBF, and standardized uptake value. Increased relative CBV and high fractional tumor burden (defined by a threshold relative CBV of ≥1.75) best differentiated tumor from radiation necrosis in subjects with brain metastases treated with stereotactic radiosurgery. Performance of normalized and standardized approaches was similar.